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Background: Point of care testing for C-reactive protein (CRP) has shown promise as a measure to reduce unnecessary
antibiotic prescribing in respiratory tract infections (RTI), but its use in primary care is still controversial. We aimed to
evaluate the effect of CRP testing on the prescription of antibiotics, referral for radiography, and the outcome of patients
in general practice with acute cough/RTI.
Methods: An open-cluster randomized clinical trial was conducted, with CRP testing performed in the intervention group.
Antibiotic prescribing and referral for radiography were the main outcome measures.
Results: A total of 179 patients were included: 101 in the intervention group and 78 in the control group. The two
groups were similar in clinical characteristics. In the intervention group, the antibiotic prescribing rate was 37.6%, which
was significantly lower than that in the control group (58.9%) (P = 0.006). Referral for chest X-ray was also significantly
lower in the intervention group (55.4%) than in the control group (75.6%) (P = 0.004). The recovery rate, as recorded by
the GPs, was 92.9% and 93.6% in the intervention and control groups, respectively.
Conclusion: The study showed that CRP testing in patients with acute cough/RTI may reduce antibiotic prescribing and
referral for radiography, probably without compromising recovery.
Trial registration: The trial was registered in the ClinicalTrials.gov Protocol Registration System (identification number:
NCT01794819).
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European medical professionals are concerned about the
overuse of antibiotics and increased levels of bacterial re-
sistance [1,2]. Lower respiratory tract infections (LRTI) and
cough are two of the most common reasons in Europe for
consulting a general practitioner (GP) [3]. Between 80%
and 90% of all antibiotics are prescribed in primary care,
mostly for respiratory tract infections (RTI) [1]. The fre-
quency of antibiotic prescribing in patients with acute
cough varies widely between European countries (from 28%* Correspondence: klmn.69@mail.ru
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distribution, and reproduction in any mediumto 92%) [4]. From a public health perspective, the major
focus of the recent European Respiratory Society (ERS)
guidelines for the management of LRTI is appropriate pre-
scription of antibiotics [3].
In the Arkhangelsk region of the Russian Federation,
community-acquired respiratory infections are common in
general practice, constituting 40% of all consultations in
adults [5]. About two-thirds of all antibiotics prescribed are
for treatment of such infections. Selecting the right patients
for antibiotic treatment is a major diagnostic challenge for
general practitioners who are caring for patients with acute
community-acquired LRTI, infectious exacerbations of
asthma, or chronic obstructive pulmonary disease (COPD).
The main problems in the management of patients with
LRTI in primary care are, on the one hand, prescriptions ofd Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited.
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the infection is usually self-limiting, and, on the other hand,
the risk of missing treatment of life-threatening pneumonia
[6-8]. Differentiation between viral and bacterial LRTI
would have therapeutic implications, but common clinical
signs have low sensitivity and specificity for bacterial infec-
tion, and standard microbiological examinations are, in
most cases, not practical in primary care [7]. Diagnostic
uncertainty and an over-reliance on abnormal lung sounds
on auscultation [3,9] can be reasons for overprescribing
antibiotics in patients with acute cough, as are patient ex-
pectation and demand [10]. Evidence-based antibiotic pre-
scribing can be promoted in several ways, one of which
could be the application of point-of-care testing (POCT)
for C-reactive protein (CRP), an acute-phase protein that
shows increased levels in serum during infection and tissue
damage [11].
Rapid tests for CRP were introduced into general prac-
tice about 20 years ago. They are widely used in Nordic
countries, mostly in cases of upper respiratory tract in-
fection (URTI) and LRTI (from 31% to 74% of cases)
[8,9,12,13]. The antibiotic prescription rate is also rela-
tively low in these countries, as shown in a European
study carried out in a primary care setting [4,14]. Rapid
CRP tests had not been used in primary care in the
Arkhangelsk region before the start of this study.
In most cases, the CRP test cannot differentiate be-
tween bacterial and viral infections [15], but it does help
to decrease diagnostic uncertainty [16]. Most patients
consulting in general practice have CRP levels less than
20 mg/L [8,9]. By avoiding the administration of antibi-
otics to patients with such low CRP values, unnecessary
use of antibiotics may be reduced [17]. Although the
strong association between CRP value and the presence
of pneumonia is well documented [6,7,18], evidence
showing that the test can be used by GPs to improve ra-
tional use of antibiotics in LRTI is still sparse and uncer-
tain [17,19-21]. However, the use of CRP testing in
primary care has been recommended in the latest Euro-
pean guidelines for treatment of LRTI [3]. The Russian
guidelines concerning community-acquired pneumonia
recommend CRP testing as an optional investigation
[22]. These guidelines indicate that chest radiography is
mandatory when pneumonia is suspected [22].
A recently published systematic review and meta-
analysis of primary care studies [23] pointed to a role of
POCT for CRP in significantly reducing antibiotic pre-
scribing at the index consultation for patients with RTIs.
The aim of this study was to evaluate the usefulness in
Russian general practice of CRP testing in patients with
acute cough/RTI. In addition to studying the effect of
CRP testing on the prescription of antibiotics, we
wanted to find out whether the frequency of referral for
radiography could be reduced.Methods
Setting
Eighteen general practitioners (GPs), nine from the
Arkhangelsk region and nine from the Murmansk region,
from both urban and rural offices, were randomized into
intervention and control groups. The trial was conducted
over 12 weeks (from 30 January to 30 April 2010). All regis-
trations were made by GPs in their offices.Study population
Patients with acute cough/LRTI (including acute bronchitis,
pneumonia, and infectious exacerbations of COPD or
asthma) were included. Other inclusion criteria were age
18 years or older, an illness of less than 28 days duration,
first consultation for the illness episode, being seen in a
physician’s office, and written consent to participate. Ex-
clusion criteria were an inability to fill out study docu-
mentation, being previously included in the study,
immunocompromised status (HIV patients, immuno-
suppressive treatment), and ongoing treatment with oral
corticosteroids.Design
Cluster randomization was performed with GPs as units
with SPSS 18.0 (IBM, Armonk, NY, USA). The rationale
for using a cluster design was to ensure consecutive re-
cruitment of patients and to avoid the situation where
experience gained from the use of the test contaminated
the care of control patients.
The second author generated the allocation sequence
using SPSS, and the first author enrolled the clusters and
made a list of clusters. Based on this list and using the allo-
cation sequence, the first author assigned clusters to
interventions.
All the GPs worked in separate outpatient depart-
ments (polyclinics), some in single GP offices and others
within a GP partnership (with doctors who did not par-
ticipate in this study). The sample sizes were based on a
hypothesis of 20% reduction in antibiotic prescribing in
the intervention group compared with the control
group. Based on the chi-square statistic, the required
sample size in each group was 72 participants (with a
power of 90% and a risk of false positive difference less
than 5%).
Two months before the trial, a baseline study without
CRP testing was conducted that included 13 of the 18
participating GPs, using the same case report form
(CRF) and examination. This allowed observation of pre-
scription rates before and after the clinical trial, serving
as a sensitivity analysis.
The CONSORT checklist and flow diagram are in-
cluded as additional files.
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The CRF was similar to that used in the GRACE study
(Genomics to combat Resistance against Antibiotics in
Community-acquired lower respiratory tract infections
in Europe [24]), describing symptoms, findings, and
treatment in LRTI [4]. The GPs reported the following
15 symptoms in a questionnaire: cough, sputum pro-
duction, shortness of breath, wheeze, coryza (blocked/
runny nose), fever during this illness, chest pain,
muscle aches, headache, disturbed sleep, feeling gener-
ally unwell, interference with normal activities, confu-
sion/disorientation, and diarrhoea. If increased sputum
production was reported, the colour of the sputum was
recorded. Symptom severity scores were calculated
using the scores for 13 symptoms (similar to that com-
puted in the GRACE study) [4]. The categories for cli-
nicians to rate the severity of each symptom as “no
problem”, “mild problem”, “moderate problem”, or “se-
vere problem” were scored 1, 2, 3, and 4, respectively.
Scores were calculated for patients with a minimum of
85% (that is, 12 of 14 symptoms) of their symptoms re-
corded. This score was scaled to range between 0 and
100 so that it could be interpreted as a percentage of
maximum symptom severity.
Other variables registered included sex, age and
smoking status (never smoker, previous smoker and
current smoker). For previous and current smokers, the
average number of cigarettes per day and the number
of smoking years were recorded. The pack-year criter-
ion was calculated: one pack-year of smoking would
mean that someone had smoked one pack of cigarettes
(20 cigarettes) daily for one year.
The clinical examination included a chest examin-
ation and axillary temperature. The following chest
findings were recorded: diminished vesicular breathing,
wheezes, crackles and rhonchi.
After the clinical examination, the GPs recorded their
provisional diagnosis, choosing from the following:
URTI, acute bronchitis, pneumonia, COPD, asthma,
non-infectious cough, and other diagnosis.
The comorbidities registered were: 1) pulmonary dis-
eases, including COPD, asthma, tuberculosis, bronchi-
ectasis, lung cancer, and other lung disease; 2) heart
diseases, including heart failure, ischaemic heart dis-
ease, and other heart diseases (e.g., valvular lesions, car-
diomyopathy); 3) diabetes; and 4) other chronic
diseases.Optional examinations
Chest radiography was accessible for all patients, and
other investigations (e.g., culture of sputum, spirometry,
electrocardiogram) could be ordered when necessary. All
suspected pneumonia cases were confirmed by chestradiography, and films were routinely reviewed by spe-
cialists at radiology departments.
CRP testing
Before the clinical trial began, all GPs participated in
two vocational training sessions concerning the CRP
test, including theoretical and practical information.
They were given guidelines about the interpretation of
CRP results. This information included a summary of
the literature on RTI and the role of CRP; paper cases
of patients with different RTIs and different CRP values
were discussed. They were told that antibiotics were
usually not needed when the CRP value was below
20 mg/L and that a prescription could be indicated for
CRP values above 50 mg/L, taking into account the
duration of illness [15]. However, the management, in-
cluding antibiotic treatment, should be decided for each
patient on an individual basis.
The CRP test was performed in the intervention
group at both the first and second consultations. The
Afinion test system (Axis Shield) was used, which pro-
vides results within 5 minutes and before treatment is
determined. This test is based on solid-phase sandwich
immunometric analysis. The measurement range in
whole blood samples is 8–200 mg/L. Test kits were
supplied by Axis Shield.
Treatment
GPs could prescribe any treatment, including antibi-
otics and other drugs for the cough (e.g., cough mix-
ture) and additional medication if deemed necessary.
They were told that medication should be prescribed
after the clinical examination (and after the CRP test in
the intervention group), without waiting for chest radi-
ography results.
Outcome measures
The primary outcome was the antibiotic prescribing
rate. Secondary outcomes were referral to radiography
and rate of recovery at the follow-up consultation after
2 weeks with the following five alternatives: “fully
recovered”, “almost recovered”, “slightly improved”,
“unchanged”, and “worse”. Reconsultations (another
consultation with the GP within 2 weeks) and compli-
cations (in need of hospitalization) were recorded.
Statistical analysis
CRP values were divided into three groups: CRP <
20 mg/L, 20–50 mg/L and ≥ 50 mg/L. Differences in
the rate of prescribing antibiotics and referral to chest
radiography were calculated, as was the percentage of
participants who stated that they had recovered or al-
most recovered after 2 weeks. Differences in patient
characteristics at inclusion between the intervention
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cruitment bias. Changes in prescription rate between
baseline and the clinical trial for each GP were analysed
as part of the sensitivity analyses. The chi-square test
was used to assess differences, and a P-value < 0.05 was
considered to indicate significance. As a second sensi-
tivity analysis, the predictive value of CRP testing for
antibiotic prescribing was evaluated by multivariableTable 1 Patient characteristics and findings in primary care p
Intervention group, CRP te
n (%
Male 29 (28
Current smokers 28 (27
Pre-existing illness:
Pulmonary diseases 15 (15
Heart diseases 17 (17
Diabetes 5 (5)




Discoloured sputum 56 (57
Shortness of breath 9 (9)
Wheeze (reported) 9 (9)
Coryza 19 (19
Fever (history of) 31 (31
Chest pain 5 (5)
Muscle aches 13 (13
Headache 19 (19
Disturbed sleep 10 (10
Feeling unwell 47 (46








Any abnormal lung sound 60 (59
Temperature≥ 37.2°C 51 (50
CRP≥ 20 and < 50 mg/L 13 (13
CRP≥ 50 mg/L 7 (7)
Perceived patient preference for antibiotics3 10 (10
1CRP = C-reactive protein.
2Reported by patient to be a moderate or severe problem.
3Symptom severity scores calculated using the scores for 13 symptoms that were s
4The general practitioner agreed that the patient wanted her/him to prescribe antiblogistic regression, in a model including other relevant
explanatory variables.
Statistical analysis was performed using SPSS 18.0.
Ethics
All patients gave informed consent. The study was ap-
proved by the local Ethics Committee of the Northern
State Medical University (Arkhangelsk, Russia).atients with acute cough categorized by CRP1 testing
sted (n = 101) Control group, CRP not tested (n = 78) P
) n (%)
) 20 (26) 0.7
) 16 (21) 0.3
) 14 (18) 0.7
) 3 (4) 0.007
3 (4) 1.0
) 39 (50) 0.6
) 48 (62) 0.9
) 21 (27) 0.3
) 49 (63) 0.4
11 (14) 0.3
17 (22) 0.02
) 9 (12) 0.2
) 26 (33) 0.7
5 (6) 0.7
) 2 (3) 0.01
) 4 (5) 0.07
) 4 (5) 0.3
) 15 (19) 0.0001
) 15 (19) 0.0007
43 0.4
(29–69)
) 30 (38) 0.2
) 19 (24) 0.6
2 (3) 1.0
3 (4) 0.5
) 54 (69) 0.2
) 49 (63) 0.1
)
) 18 (23) 0.02
ummed, and median, minimum and maximum values (in brackets) calculated.
iotics.
Figure 1 Antibiotic prescribing by confirmed (X-ray) diagnosis in the intervention and control groups. URTI = upper respiratory tract
infections, COPD = chronic obstructive pulmonary disease.
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Study population
The intervention group that underwent the CRP test con-
sisted of 101 patients recruited from four GP offices in
Arkhangelsk and four GP offices in Murmansk (51 and 50
patients, respectively). Initially, 98 patients were recruited
to the control group. During analysis, it became clear that
there were incomplete registrations in the CRFs from two
GPs, and follow-up data were frequently missing, as were
patient consent forms. To assure quality, all patients from
these two GPs were excluded from the analysis, and we
ended up with 78 patients in the control group from four
GP offices in Arkhangelsk and five GP offices in Murmansk
(51 and 27 patients, respectively). The mean age was
50.8 years in both groups. Feeling unwell and experiencing
limitations in daily activities were recorded more frequently
in the intervention group than in the control group,
whereas the severity scores were similar in the two groups.
The GPs in the control group reported more frequently
than those in the intervention group that the patients
wanted antibiotics (Table 1). The most frequent diagnoses
were URTI (50% and 41% in the intervention and controlFigure 2 Distribution (%) of CRP values by diagnosis in the interventigroup, respectively) followed by acute bronchitis. Pneumo-
nia was confirmed in 7% of the patients in the intervention
group and in 17% in the control group.
Antibiotic prescribing
The rate of antibiotic prescribing on the day of inclusion
was lower in the intervention group (37.6%) than in the
control group (58.9%) (P = 0.006). The overall antibiotic
prescribing rate during the two weeks was 40.6% in the
intervention group and 71.8% in the control group
(P = 0.0001).
Antibiotics were prescribed in all cases of suspected
pneumonia (Figure 1). The second most frequent reason
for prescribing antibiotics was acute bronchitis (64% and
68% in the intervention and control groups, respect-
ively). The most frequently used antibiotic was amoxicil-
lin, often in combination with clavulanic acid, prescribed
for 73% and 72% of those given antibiotics in the inter-
vention and control groups, respectively.
The mean CRP level in the intervention group was
11.5 ± 24.4 mg/L. Most of the patients with pneumonia
had CRP values > 50 mg/L, whereas none of the URTIon group. CRP = C-reactive protein.
Figure 3 Frequency (%) of prescribing antibiotics by CRP value in the intervention group. CRP = C-reactive protein.
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CRP value was higher than 20 mg/L, 85% of the patients
were prescribed antibiotics, compared with 28% when
the CRP value was below 20 mg/L (P = 0.0002)
(Figure 3).
Radiography
The referral rate for chest radiography was significantly
lower in the intervention group (55.4%) than in the con-
trol group (76%) (P = 0.004). All patients with a clinical
diagnosis of pneumonia were referred for radiography,
whereas the lowest frequency of referral was for patients
diagnosed with URTI (45% and 37% in the intervention
and control groups, respectively).
Recovery
The frequency of reporting “almost recovered” or “fully
recovered” after 2 weeks was 91.1% in the intervention
group and 92.3% in the control group, but “fully recov-
ered” was most frequently reported in the intervention
group (Table 2). All patients had recovered to some de-
gree; no patients had become worse.
Sensitivity analyses
Comparisons with the baseline study
Thirteen of the 18 GPs who took part in the clinical trial
also participated in the baseline study I, which included
52 patients above the age of 18 in Arkhangelsk and 46
in Murmansk. The rate of referral for X-ray examination
in the baseline study was 70.1%, and the antibiotic pre-
scribing rate was 63.3%. The clinical recovery rate (theTable 2 Clinical recovery rate in the clinical trial
Intervention group, n (%) Control group, n (%)
Fully recovered 55 (54.4%) 26 (33.3%)
Almost recovered 37 (36.6%) 46 (58.9%)
Slightly improved 7 (6.9%) 5 (6.4%)percentage of patients who were “fully recovered” or “al-
most recovered”) was 87.7%. Antibiotic prescribing rates
in the baseline study and in the clinical trial by the four
GPs randomized to the control group and the seven GPs
randomized to the intervention group are compared in
Table 3. A reduction in the prescribing rate of five of
seven GPs in the intervention group was observed,
whereas only one of the six GPs in the control group
had reduced their prescribing rate.
Evaluating the intervention by multivariable analysis
When the effect of the intervention was analysed by multi-
variable logistic regression with antibiotic prescribing as
outcome variable and allocation to CRP testing, URTI diag-
nosis, symptom score, any chest finding, any comorbidity,
and perceived patient preference for antibiotic as explana-
tory variables, the OR of allocation to CRP testing was 0.4
(95% confidence interval [CI] 0.18–0.89). Symptom score
and perceived patient preference for antibiotics were signifi-
cant positive predictors of antibiotic prescribing in this
model, whereas URTI diagnosis was a significant negative
predictor.
Discussion
This study demonstrated that the rate of antibiotic pre-
scribing and referral to radiography could be reduced by
the introduction of POCT for CRP. This reduction was
most likely obtained without decreasing the patient re-
covery rate.
Some previous studies have failed to find an effect of
CRP testing on antibiotic prescribing [19,20]. In a study
from 1995 by Melbye and co-workers, the use of a rapid
CRP test did not lead to a reduced rate of antibiotic pre-
scribing in patients with LRTI [20]. Low levels of trust in
the test at that time probably led to frequent prescribing,
even in patients with low CRP values. A study by Gonzales
and co-workers also indicated that the CRP test provided
no additional value beyond clinical decision support in
















GP A 6 2 (33) 12 8 (66) 0.3
GP B 4 2 (50) 14 7 (50) 1.0
GP C 6 4 (66) 8 8 (100) 0.2
GP D 5 5 (100) 8 8 (100) 1.0
GP E 6 2 (33) 10 6 (60) 0.6
GP F 7 6 (86) 10 7 (70) 0.6
Total 34 21 (62) 62 44 (71) 0.4
Intervention
group
GP G 7 2 (28) 19 8 (42) 0.7
GP H 6 5 (83) 10 4 (40) 0.1
GP J 5 5 (100) 10 6 (60) 0.2
GP K 7 2 (28) 12 1 (8) 0.5
GP L 9 3 (33) 10 0 (0) 0.1
GP M 7 7 (100) 10 4 (40) 0.08
GP N 6 4 (66) 10 7 (70) 1.0
Total 47 28 (59) 81 30 (37) 0.02
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[19]. In this study, patients with a CRP level as low as 10–
20 mg/L could be treated with antibiotics according to the
algorithm in the CRP group, which may be one reason for
the increased prescribing rate in those tested for CRP.
In contrast to the negative findings of these two stud-
ies, Cals and co-workers showed that the use of CRP
testing significantly reduced antibiotic prescribing for
LRTI without decreasing the quality of care and the out-
come of treatment [25]. The results of our study were
similar to those of Cals et al., who also found that multi-
faceted interventions in addition to the use of the CRP
test gave additional benefits: they found that it was valu-
able to provide guidance to GPs in communication skills
[25]. In a recent study of 621 adult patients with acute
cough or fever, 20.5% of whom had radiographically con-
firmed pneumonia, Steurer and co-workers concluded
that pneumonia could safely be excluded in patients with
CRP values below 10 mg/L and in patients without dys-
pnoea or daily fever with values between 11 and 50 mg/
L [21]. The CRP test has also recently been found to be
useful in identifying patients with COPD exacerbations
who do not need antibiotic treatment [26].
In 2012, Engel et al. published a systematic review ti-
tled “Evaluating the evidence for the implementation of
C-reactive protein measurement in adult patients with
suspected lower respiratory tract infection in primary
care” [27]. Most of the studies that were reviewedshowed limited evidence for the usefulness of CRP
measurement in adult patients in primary care with sus-
pected LRTI [27]. Only one study (Cals et al. [25]) pro-
vided firm evidence that a reduction in antibiotic
prescriptions could be achieved when CRP measurement
was applied [27].
The CRP test may be most useful in patients with an
intermediate risk of pneumonia. Van Vugt et al., when
evaluating the CRP test, concluded that “A clinical rule
based on symptoms and signs to predict pneumonia in
patients presenting to primary care with acute cough
performed best in patients with mild or severe clinical
presentation” [28]. The prevalence of pneumonia in our
study was somewhat higher than in the study by van
Vugt et al. This can possibly be explained by seasonal
variation in morbidity (winter–spring). The geographical
location of the participating GPs (northern part of
Russia) and the absence of vaccination against pneumo-
coccal infections in this area can probably also be taken
into account.
In a recent meta-analysis of 13 studies in primary care in-
cluding 10,005 patients, CRP testing led to significantly re-
duced antibiotic prescribing at the index consultation.
However neither the reduction in antibiotic prescribing at
any time during the 28-day follow-up period nor the in-
crease in patient satisfaction was significant [23]. The au-
thors emphasized that future studies are needed to analyse
the confounders that lead to this heterogeneity.
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In the Arkhangelsk region, POC testing for CRP had not
been used in primary care before this study. GPs may
need time to become more experienced in the use of
CRP testing and to become confident in interpreting the
results. The documentation of the test’s diagnostic prop-
erties and its popularity in primary care in Nordic coun-
tries may have made it easier for the GPs in the
intervention group to rely on the test results.
The cluster randomization with a small number of pa-
tients in each unit made it more likely that differences
between the intervention group and the control group
could occur [29]. However, the uncertainty was reduced
by finding a similar effect of the intervention in multi-
variable analysis. The results were also supported by the
comparison with the baseline study. The fact that the
GPs did not use CRP testing in their practice before the
study made this comparison possible.
Recovery rates were evaluated by the GP and the patient
together at the follow-up consultation after two weeks. GPs
were aware of the purpose of the trial, and they recruited
and treated patients and assessed the clinical outcome to-
gether with patients in an unblinded fashion and without
standardized criteria. Because of this, the recovery data
have to be interpreted with caution. Regrettably, we were
missing data on the duration of illness at randomization.
Clinical implications
CRP results have been demonstrated to influence strongly
the decision about whether to prescribe antibiotics for
acute cough, with a steep increase in prescribing with in-
creased CRP values [8,9,12]. However, when GPs think that
the patient wants antibiotic treatment, they frequently pre-
scribe antibiotics in spite of a low CRP value [9]. Commu-
nication skills are important in order to convince the
patient that antibiotics are not needed. Results from CRP
testing may be helpful in such an argument [9]. Using CRP
testing in addition to a thorough physical examination can
develop more trust between patient and doctor, and im-
prove satisfaction with the consultation [17].
The new European guidelines for the management of
adult LRTI do not indicate strong scepticism about the
use of the test [3]. According to these guidelines, CRP
testing can be done in patients with suspected pneumo-
nia [3]. In cases of persistent doubt after CRP testing, a
chest X-ray should be considered to confirm or reject
the diagnosis [3].
Conclusions
Our study confirms that the use of POCT for CRP may re-
duce the rate of antibiotic prescription for acute cough/RTI.
Careful use and interpretation of CRP testing in patients
with RTI has the potential to benefit patients and to help
GPs in the important struggle against antibiotic resistance.Competing interests
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